Ionis Pharmaceuticals Inc.

(IONS) Trade

By |

Profile

Ionis Pharmaceuticals is the leading developer of antisense technology to discover and develop novel drugs. Ionis' broad clinical and preclinical pipeline consists treats a wide variety of diseases, with an emphasis on cardiovascular, metabolic, severe, and rare diseases. Ionis sold rights to its first product, Kynamro, to Kastle Therapeutics after lackluster commercial success, but with partner Biogen brought its second drug, Spinraza for spinal muscular atrophy, to market.

Contact Information

Website: www.ionispharma.com
Email: rdrechsler@strategicmetalsltd.com
Main Phone: +1 760 931-9200
Address: 2855 Gazelle Court
Address 2: Suite 1016
State: CA
City / Town: Carlsbad
Country: USA
Postal Code: 92010

Issuer Information

Exchange: NGS
CEO: Stanley T. Crooke
Employees: 547
NAICS: Pharmaceutical Preparation Manufacturing(325412)


Gathering Data... Please wait

Profile

Ionis Pharmaceuticals is the leading developer of antisense technology to discover and develop novel drugs. Ionis' broad clinical and preclinical pipeline consists treats a wide variety of diseases, with an emphasis on cardiovascular, metabolic, severe, and rare diseases. Ionis sold rights to its first product, Kynamro, to Kastle Therapeutics after lackluster commercial success, but with partner Biogen brought its second drug, Spinraza for spinal muscular atrophy, to market.

Contact Information

Website: www.ionispharma.com
Email: rdrechsler@strategicmetalsltd.com
Main Phone: +1 760 931-9200
Address: 2855 Gazelle Court
Address 2: Suite 1016
State: CA
City / Town: Carlsbad
Country: USA
Postal Code: 92010

Issuer Information

Exchange: NGS
CEO: Stanley T. Crooke
Employees: 547
NAICS: Pharmaceutical Preparation Manufacturing(325412)
$ 57.60 $ 0.42 (0.73%)
Last Price 57.60 Change $ 0.42 Change % 0.73 Tick N/A
Bid 56.21 Bid Size 500.00 Ask 58.75 Ask Size 100.00
Open 56.97 High 58.19 Low 56.63 Prev Close 57.18
Last Trade Volume 694,737 52 Wk Hi 59.81 52 Wk Low 39.07
Market Cap 7.9 bi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 137,571,510.00 EPS (TTM) -0.38 PE Ratio N/A Exchange NGS
  Last 3 Mo Last 12 Mo
Number of Insider Trades 26 185
Number of Buys 13 101
Number of Sells 13 84
Net Activity 0 66508
Last 10 Buys Shares
N/A 0
Last 10 Sell Shares
Frederick T. Muto 1,000
C. Frank Bennett 1,000
Joseph H. Wender 1,000
Joseph H. Wender 1,000
Joseph H. Wender 1,000
Stanley T. Crooke 1,000
Stanley T. Crooke 1,000
Stanley T. Crooke 1,000
Stanley T. Crooke 1,000
Joseph Klein 1,000
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 106 106 106 106
Low Target Price Estimate 45 45 45 45
Mean Target Price Estimate 59.56 63.13 63.13 59.56
Standard Deviation 19.4 19.5 19.5 19.4
Date of Most Recent Estimate 05/31/18 05/23/18 05/08/18 05/31/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 2 2 3 3
Moderate Buy 0 0 0 0
Hold 8 7 6 6
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 2.6 2.56 2.33 2.33